Diet-derived circulating antioxidants and risk of inflammatory bowel disease: a Mendelian randomization study and meta-analysis

被引:9
作者
Zou, Menglong [1 ]
Liang, Qiaoli [2 ]
Zhang, Wei [1 ]
Liang, Junyao [1 ]
Zhu, Ying [1 ]
Xu, Yin [1 ]
机构
[1] Hunan Univ Chinese Med, Dept Gastroenterol, Hosp 1, Changsha, Hunan, Peoples R China
[2] Doumen Qiaoli Hosp Tradit Chinese Med, Dept Oncol, Zhuhai, Peoples R China
基金
中国国家自然科学基金;
关键词
diet-derived circulating antioxidants; inflammatory bowel disease; causal relationship; Mendelian randomization; meta-analysis; ASSOCIATION;
D O I
10.3389/fimmu.2024.1334395
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Previous studies have shown conflicting results regarding the impact of circulating antioxidants on the risk of inflammatory bowel disease (IBD). In this study, our intent was to investigate the causal relationship between circulating antioxidants and IBD using Mendelian randomization (MR).Methods Instrumental variables for absolute circulating antioxidants (ascorbate, retinol, lycopene, and beta-carotene) and circulating antioxidant metabolites (alpha-tocopherol, gamma-tocopherol, ascorbate, and retinol) were screened from published studies. We obtained outcome data from two genome-wide association study (GWAS) databases, including the international inflammatory bowel disease genetics consortium (IIBDGC, 14,927 controls and 5,956 cases for Crohn's disease (CD), 20,464 controls and 6,968 cases for ulcerative colitis (UC), and 21,770 controls and 12,882 cases for IBD) and the FinnGen study (375,445 controls and 1,665 cases for CD, 371,530 controls and 5,034 cases for UC, and 369,652 controls and 7,625 cases for IBD). MR analysis was performed in each of the two databases and those results were pooled using meta-analysis to assess the overall effect of exposure on each phenotype. In order to confirm the strength of the findings, we additionally conducted a replication analysis using the UK Biobank.Results In the meta-analysis of the IIBDGC and FinnGen, we found that each unit increase in absolute circulating level of retinol was associated with a 72% reduction in the risk of UC (OR: 0.28, 95% CI: 0.10 to 0.78, P=0.015). The UC GWAS data from the UK Biobank also confirmed this causal relationship (OR: 0.99, 95% CI: 0.97 to 1.00, P=0.016). In addition, there was suggestive evidence that absolute retinol level was negatively associated with IBD (OR: 0.41, 95% CI: 0.18 to 0.92, P=0.031). No other causal relationship was found.Conclusion Our results provide strong evidence that the absolute circulating level of retinol is associated with a reduction in the risk of UC. Further MR studies with more instrumental variables on circulating antioxidants, especially absolute circulating antioxidants, are needed to confirm our results.
引用
收藏
页数:10
相关论文
共 42 条
[11]   Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease [J].
Gordon, Benjamin Langan ;
Galati, Jonathan S. ;
Yang, Stevie ;
Longman, Randy S. ;
Lukin, Dana ;
Scherl, Ellen J. ;
Battat, Robert .
WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (33) :4834-4845
[12]   Influence of Severe Vitamin D Deficiency on the Clinical Course of Inflammatory Bowel Disease [J].
Ham, Nam Seok ;
Hwang, Sung Wook ;
Oh, Eun Hye ;
Kim, Jeongseok ;
Lee, Ho-Su ;
Park, Sang Hyoung ;
Yang, Dong-Hoon ;
Ye, Byong Duk ;
Byeon, Jeong-Sik ;
Myung, Seung-Jae ;
Yang, Suk-Kyun .
DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (02) :587-596
[13]  
Hashemi J, 2013, SAUDI MED J, V34, P432
[14]   β-Carotene 15,15′ -monooxygenase 1 single nucleotide polymorphisms in relation to plasma carotenoid and retinol concentrations in women of European descent [J].
Hendrickson, Sara J. ;
Hazra, Aditi ;
Chen, Constance ;
Eliassen, A. Heather ;
Kraft, Peter ;
Rosner, Bernard A. ;
Willett, Walter C. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2012, 96 (06) :1379-1389
[15]   Crohn's disease:: the cold chain hypothesis [J].
Hugot, JP ;
Alberti, C ;
Berrebi, D ;
Bingen, E ;
Cézard, JP .
LANCET, 2003, 362 (9400) :2012-2015
[16]   PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations [J].
Kamat, Mihir A. ;
Blackshaw, James A. ;
Young, Robin ;
Surendran, Praveen ;
Burgess, Stephen ;
Danesh, John ;
Butterworth, Adam S. ;
Staley, James R. .
BIOINFORMATICS, 2019, 35 (22) :4851-4853
[17]   Ameliorative Effect of High-Dose Vitamin C Administration on Dextran Sulfate Sodium-Induced Colitis Mouse Model [J].
Kondo, Kanako ;
Hiramoto, Keiichi ;
Yamate, Yurika ;
Goto, Kenji ;
Sekijima, Hidehisa ;
Ooi, Kazuya .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (06) :954-959
[18]   Oxidative Stress and Antioxidants-A Critical Review on In Vitro Antioxidant Assays [J].
Kotha, Raghavendhar R. R. ;
Tareq, Fakir Shahidullah ;
Yildiz, Elif ;
Luthria, Devanand L. L. .
ANTIOXIDANTS, 2022, 11 (12)
[19]   FinnGen provides genetic insights from a well-phenotyped isolated population [J].
Kurki, Mitja, I ;
Karjalainen, Juha ;
Palta, Priit ;
Sipila, Timo P. ;
Kristiansson, Kati ;
Donner, Kati M. ;
Reeve, Mary P. ;
Laivuori, Hannele ;
Aavikko, Mervi ;
Kaunisto, Mari A. ;
Loukola, Anu ;
Lahtela, Elisa ;
Mattsson, Hannele ;
Laiho, Paivi ;
Parolo, Pietro Della Briotta ;
Lehisto, Arto A. ;
Kanai, Masahiro ;
Mars, Nina ;
Ramo, Joel ;
Kiiskinen, Tuomo ;
Heyne, Henrike O. ;
Veerapen, Kumar ;
Rueger, Sina ;
Lemmela, Susanna ;
Zhou, Wei ;
Ruotsalainen, Sanni ;
Parn, Kalle ;
Hiekkalinna, Tero ;
Koskelainen, Sami ;
Paajanen, Teemu ;
Llorens, Vincent ;
Gracia-Tabuenca, Javier ;
Siirtola, Harri ;
Reis, Kadri ;
Elnahas, Abdelrahman G. ;
Sun, Benjamin ;
Foley, Christopher N. ;
Aalto-Setala, Katriina ;
Alasoo, Kaur ;
Arvas, Mikko ;
Auro, Kirsi ;
Biswas, Shameek ;
Bizaki-Vallaskangas, Argyro ;
Carpen, Olli ;
Chen, Chia-Yen ;
Dada, Oluwaseun A. ;
Ding, Zhihao ;
Ehm, Margaret G. ;
Eklund, Kari ;
Farkkila, Martti .
NATURE, 2023, 613 (7944) :508-+
[20]   TRAF5 regulates intestinal mucosal Th1/Th17 cell immune responses via Runx1 in colitis mice [J].
Li, Mengting ;
Gan, Caiqin ;
Zhang, Runan ;
Wang, Jiahui ;
Wang, Youwei ;
Zhu, Weining ;
Liu, Lan ;
Shang, Jian ;
Zhao, Qiu .
IMMUNOLOGY, 2023, 170 (04) :495-509